bEV-mediated synaptic pruning via C1q-C3 pathway

Exploratory Score: 0.850 Price: $0.50 Alzheimer's disease microglia and synapses (in vivo and in vitro) Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting C1q, C3 in microglia and synapses (in vivo and in vitro). Primary outcome: synaptic pruning mediated by complement pathway

Description

This experiment examined how bacterial extracellular vesicles trigger excessive synaptic pruning through activation of the complement cascade, specifically the C1q-C3 pathway. The study investigated the molecular mechanisms by which bEV-activated microglia mediate synaptic loss, a key pathological feature in Alzheimer's disease. The research likely involved measuring synaptic markers, complement protein expression, and synaptic connectivity in response to bEV treatment, demonstrating a direct link between gut microbiota-derived vesicles and synaptic pathology.

TARGET GENE
C1q, C3
MODEL SYSTEM
microglia and synapses (in vivo and in vitro)
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
complement cascade, synaptic pruning
SOURCE
extracted_from_pmid_40731189
PRIMARY OUTCOME
synaptic pruning mediated by complement pathway

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

C3 — Complement Component 3geneC1QA Gene — Complement Component 1q A ChaingeneC1Q Protein (Complement Component 1q)proteinC3 Protein (Complement Component 3)proteinAlzheimer's Disease Genetic VariantsdiseaseAlzheimer's Disease vs Parkinson's Disease ComparidiseaseAPP Mutations in Alzheimer's DiseasediseaseDLB, Parkinson's Disease, and Alzheimer's Disease:diseaseEarly-Onset Alzheimer's Disease (EOAD)diseaseInvestment Landscape: Alzheimer's DiseasediseasePreclinical Alzheimer's DiseasediseaseMicrogliacellPSEN1 Mutations in Alzheimer's DiseasediseasePSEN2 Mutations in Alzheimer's DiseasediseaseSporadic vs Familial Alzheimer's Disease: Comprehedisease

Protocol

Investigation of bEV effects on synaptic pruning through C1q-C3 complement pathway activation

Expected Outcomes

bEVs cause excessive synaptic pruning via complement activation

Success Criteria

Demonstration of increased synaptic loss and complement pathway activation following bEV treatment

Related Hypotheses (5)

TREM2-mediated microglial tau clearance enhancement0.618
Synaptic Pruning Precision Therapy0.612
LRP1-Dependent Tau Uptake Disruption0.600
IGFBPL1-Mediated Homeostatic Restoration0.584
Extracellular Vesicle Biogenesis Modulation0.582

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.